Literature DB >> 7357798

Interaction of levodopa and metoclopramide on gastric emptying.

D M Berkowitz, R W McCallum.   

Abstract

Dopamine is postulated as an inhibitory neurotransmitter in the alimentary tract. The purposes of this study were to determine the effect of levodopa on the rate of gastric emptying in man and to investigate the interaction of levodopa and metoclopramide (a putative dopamine antagonist) on gastric emptying. On separate days, 7 normal male subjects received oral levodopa, 1,000 mg, and placebo in a randomized double-blind fashion 20 min before taking a mixed solid-liquid test meal labeled with 99mtechnetium(Tc)-diethylenetriamine pentaacetic acid. Gastric emptying was measured over 90 min by a gamma camera technique. At 90 min, the mean percent isotope remaining in the stomach after placebo, 54.7 +/- 5.0%, was less than after levodopa, 85.1 +/- 4.9% (p less than 0.01). Four of these normal subjects were studied further, and received levodopa, 1,000 mg, and metoclopramide, 10 mg, by intramuscular injection, 20 min before the same labeled test meal. In these 4 subjects, at 90 min, mean percent isotope remaining in the stomach after the combination of levodopa and metoclopramide, 48.5 +/- 2.2%, was less than after levodopa alone, 83.3 +/- 7.0% (p less than 0.05), and in the same range as mean percent after placebo, 47.3 +/- 3.6%. It is concluded that (1) levodopa inhibited gastric emptying of isotope in a mixed solid-liquid meal in normal subjects; (2) metoclopramide antagonized this effect returning gastric emptying to normal; and (3) the data suggest the possibility that dopaminergic receptors have an inhibitory effect on gastric emptying of the human stomach.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357798     DOI: 10.1038/clpt.1980.55

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  18 in total

1.  Slow gastric emptying induced by high fat content of meal accelerated by cisapride administered rectally.

Authors:  G Stacher; G V Granser; H Bergmann; A Kugi; G Stacher-Janotta; J Höbart
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

2.  The influence of levodopa on gastric emptying in man.

Authors:  D R Robertson; A G Renwick; N D Wood; N Cross; B S Macklin; J S Fleming; D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

3.  Impaired circadian rhythm of gastric myoelectrical activity in patients with multiple system atrophy.

Authors:  Atsuya Suzuki; M Asahina; C Ishikawa; K M Asahina; K Honma; T Fukutake; T Hattori
Journal:  Clin Auton Res       Date:  2005-12       Impact factor: 4.435

4.  Unchanged gastric emptying and visceral perception in early Parkinson's disease after a high caloric test meal.

Authors:  L Epprecht; S R Schreglmann; O Goetze; D Woitalla; C R Baumann; D Waldvogel
Journal:  J Neurol       Date:  2015-06-06       Impact factor: 4.849

5.  Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats.

Authors:  Lixin Wang; Sachiko Mogami; Hiroshi Karasawa; Chihiro Yamada; Seiichi Yakabi; Koji Yakabi; Tomohisa Hattori; Yvette Taché
Journal:  Peptides       Date:  2014-03-11       Impact factor: 3.750

6.  The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig.

Authors:  B Costall; S J Gunning; R J Naylor; M B Tyers
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

7.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

8.  Definition of a gastric emptying abnormality in patients with anorexia nervosa.

Authors:  R W McCallum; B B Grill; R Lange; M Planky; E E Glass; D G Greenfeld
Journal:  Dig Dis Sci       Date:  1985-08       Impact factor: 3.199

Review 9.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

Review 10.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.